Policy · 117th Congress
Patients’ groups, progressives square off over Medicare Alzheimer’s decision
Patient groups, many of which have close ties to drugmakers developing treatments, say the move will block most of the country’s 6 million Alzheimer’s patients from a potential opportunity to slow